Shin KH, Lim KS, Lee H, Jang IJ, Yu KS. An assessment of the pharmacokinetics, pharmacodynamics, and tolerability of GCPGC, a novel pegylated granulocyte colony-stimulating factor (G-CSF), in healthy subjects. Invest New Drugs. 2014;32(4):636-643.

Chi YH, Lee H, Paik SH et al. Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Fimasartan, a Novel Angiotensin II Receptor Antagonist, Following Single and Repeated Oral Administration in the Fasted and Fed States in Healthy Subjects. Am J Cardiovasc Drugs. 2011 Oct 1. 1(5):335-46.

Xu Z, Lee H, Vu T, Hu C, Yan H, Baker D, Hsu B, Pendley C, Wagner C, Davis HM, Zhou H. Population Pharmacokinetics of Golimumab in Patients with Ankylosing Spondylitis: Impact of Body Weight and Immunogenicity. Int J Clin Pharmacol Ther. 2010;48(9):596-607.

Xu Z, Vu T, Lee H, Hu C, Ling J, Yan H, Baker D, Beutler A, Pendley C, Wagner C, Davis HM, Zhou H. Population Pharmacokinetics of Golimumab, an Anti-Tumor Necrosis Factor-Alpha Human Monoclonal Antibody, in Patients with Psoriatic Arthritis. J Clin Pharmacol, 2009;49:1056-1070.

Tannenbaum S, Holford NHG, Lee H, Peck C, Mould DR. Simulation of Correlated Continuous and Categorical Variables using a Single Multivariate Distribution. Journal of Pharmacokinetics and Pharmacodynamics, 2006 Dec;33(6):773-94.

Yoon YR, Cha IJ, Shon JH, Kim KA, Kim MJ, Shin JG, Park SW, Seo SS, Choi JS, Lee H. Clinical Pharmacokinetics of Transdermal Absorption of Diclofenac Diethylammonium Plaster in Healthy Volunteers, Kor J Clin Pharmacol Ther, 2000;8(1): 101-112.